{
  "pmcid": "4364063",
  "sha256": "d22392660badae9868987427635f6cf242cae6b20e50ba19ec9bffc2da08d822",
  "timestamp_utc": "2025-11-09T22:42:11.230604+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 13.836005658436218,
    "reading_ease": 22.915983796296302,
    "word_count": 243
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of ϵ-Aminocaproic Acid Pharmacokinetics in Adolescents Undergoing Spinal Fusion"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "Participants were randomised into two groups based on scoliosis diagnosis: idiopathic (n=10) and non-idiopathic (n=10)."
      },
      "Participants": {
        "score": 2,
        "evidence": "This randomised controlled trial enrolled 20 adolescents aged 12–17 years undergoing spinal fusion at a tertiary care center."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Participants were randomised into two groups based on scoliosis diagnosis: idiopathic (n=10) and non-idiopathic (n=10)."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to determine EACA pharmacokinetics and recommend dosing in this population."
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary outcome was pharmacokinetic parameter estimation over the surgical period."
      },
      "Randomisation_Allocation": {
        "score": 1,
        "evidence": "Participants were randomised into two groups based on scoliosis diagnosis: idiopathic (n=10) and non-idiopathic (n=10)."
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "Participants were randomised into two groups based on scoliosis diagnosis: idiopathic (n=10) and non-idiopathic (n=10)."
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Parameters for a typical patient included plasma clearance of 153 ml min−1 70 kg−1, intercompartmental clearance of 200 ml min−1 70 kg−1, central volume of distribution of 8.78 litre 70 kg−1, and peripheral volume of distribution of 15.8 litre 70 kg−1."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "Trial registration: NCT01408823."
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified."
      }
    },
    "total_score": 14,
    "max_score": 25
  }
}